Pharmaceutical compositions for the treatment of fungal infections

Details for Australian Patent Application No. 2007291517 (hide)

Owner Novartis AG

Inventors Mayer, Friedrich Karl

Agent Davies Collison Cave

Pub. Number AU-A-2007291517

PCT Pub. Number WO2008/025543

Priority 06119884.2 31.08.06 EP

Filing date 29 August 2007

Wipo publication date 6 March 2008

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/69 (2006.01) - Boron compounds

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/025543 Priority application(s): WO2008/025543

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291518-Salivary duct constriction systems and devices

2007291515-Polymorph of (R) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) - 1-azoni a-bicyclo- [2.2.2] octane bromide